A Meta-Analysis of Association between Remdesivir and Mortality among Critically-Ill COVID-19 Patients.

Aminah Abdul Razzack Syed Adeel Hassan Sai Kumar Reddy Pasya Greeshma Erasani Sham Kumar Dario Missael Rocha-Castellanos Alfonso López-Méndez Sarah Abdul Razzack

Published in: Infection & chemotherapy (2021)

Non-ventilated patients were associated with significant lower all-cause mortality rates. Prudent use of remdesivir is recommended in critically ill COVID-19 patients.

Keyphrases

sars cov
end stage renal disease
ejection fraction
newly diagnosed
intensive care unit
peritoneal dialysis
cardiovascular events
type diabetes
patient reported outcomes